Rasna Therapeutics Competitors and Similar CompaniesClear all
Rasna Therapeutics's competitors and similar companies include Urogen Pharma and Fennec Pharma.
 Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ||
Founding Date | Founding Date 2013 | Founding Date 2004 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ Greater London, GB Doylestown, US | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations US HQ |
Employees | Employees N/A | Employees 194362% increase | Employees 433% increase |
Valuation ($) | Valuation ($) 3.1 m | Valuation ($) 515.9 m | Valuation ($) 129.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) $44.6m (FY, 2025) |
Net income | Net income ($4.4m) (FY, 2023) | Net income ($153.5m) (FY, 2025) | Net income ($9.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company